Topical Bromfenac for Intraoperative Miosis and Pain Reduction
NCT03831984
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Cataract
Interventions
DRUG:
0,09% Bromfenac
DRUG:
0,1% sodium hyaluronate
Sponsor
Hospital de La Luz